vs
Side-by-side financial comparison of CLARIVATE PLC (CLVT) and Nomad Foods Ltd (NOMD). Click either name above to swap in a different company.
Nomad Foods Ltd is the larger business by last-quarter revenue ($834.9M vs $617.0M, roughly 1.4× CLARIVATE PLC). On growth, Nomad Foods Ltd posted the faster year-over-year revenue change (-2.6% vs -6.9%). Nomad Foods Ltd produced more free cash flow last quarter ($272.4M vs $89.2M).
Clarivate Plc is a British-American publicly traded analytics company that operates a collection of subscription-based services, in the areas of bibliometrics and scientometrics; business and market intelligence, and competitive profiling for pharmacy and biotech, patents, and regulatory compliance; trademark protection, and domain and brand protection. Clarivate calculates the impact factor of scientific journals, using data from its Web of Science product family, that also includes services...
Nomad Foods is the largest frozen food company in Europe, whose popular brands include Birds Eye, Ledo, Iglo, Findus, and Frikom. The company manufactures, sells and distributes a range of frozen food products across 22 European markets, with its headquarters in the United Kingdom. The most popular products in Nomad Foods’ portfolio include fish fingers, creamed spinach, peas and chicken. Nomad Foods is listed on the New York Stock Exchange trading under the ticker “NOMD”.
CLVT vs NOMD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $617.0M | $834.9M |
| Net Profit | $3.1M | — |
| Gross Margin | 66.8% | 25.6% |
| Operating Margin | 6.7% | 9.1% |
| Net Margin | 0.5% | — |
| Revenue YoY | -6.9% | -2.6% |
| Net Profit YoY | 101.6% | — |
| EPS (diluted) | $0.00 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $617.0M | $834.9M | ||
| Q3 25 | $623.1M | — | ||
| Q2 25 | $621.4M | — | ||
| Q1 25 | $593.7M | — | ||
| Q4 24 | $663.0M | $856.9M | ||
| Q3 24 | $622.2M | — | ||
| Q2 24 | $650.3M | — | ||
| Q1 24 | $621.2M | — |
| Q4 25 | $3.1M | — | ||
| Q3 25 | $-28.3M | — | ||
| Q2 25 | $-72.0M | — | ||
| Q1 25 | $-103.9M | — | ||
| Q4 24 | $-191.8M | $55.5M | ||
| Q3 24 | $-65.6M | — | ||
| Q2 24 | $-304.3M | — | ||
| Q1 24 | $-75.0M | — |
| Q4 25 | 66.8% | 25.6% | ||
| Q3 25 | 65.0% | — | ||
| Q2 25 | 67.2% | — | ||
| Q1 25 | 65.1% | — | ||
| Q4 24 | 65.7% | 28.5% | ||
| Q3 24 | 66.2% | — | ||
| Q2 24 | 67.2% | — | ||
| Q1 24 | 64.9% | — |
| Q4 25 | 6.7% | 9.1% | ||
| Q3 25 | 7.1% | — | ||
| Q2 25 | 1.1% | — | ||
| Q1 25 | -3.5% | — | ||
| Q4 24 | -9.4% | 11.5% | ||
| Q3 24 | 3.5% | — | ||
| Q2 24 | -36.9% | — | ||
| Q1 24 | 0.8% | — |
| Q4 25 | 0.5% | — | ||
| Q3 25 | -4.5% | — | ||
| Q2 25 | -11.6% | — | ||
| Q1 25 | -17.5% | — | ||
| Q4 24 | -28.9% | 6.5% | ||
| Q3 24 | -10.5% | — | ||
| Q2 24 | -46.8% | — | ||
| Q1 24 | -12.1% | — |
| Q4 25 | $0.00 | — | ||
| Q3 25 | $-0.04 | — | ||
| Q2 25 | $-0.11 | — | ||
| Q1 25 | $-0.15 | — | ||
| Q4 24 | $-0.27 | — | ||
| Q3 24 | $-0.09 | — | ||
| Q2 24 | $-0.46 | — | ||
| Q1 24 | $-0.14 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $329.2M | — |
| Total DebtLower is stronger | $4.3B | $2.5B |
| Stockholders' EquityBook value | $4.8B | $2.7B |
| Total Assets | $11.1B | $6.8B |
| Debt / EquityLower = less leverage | 0.89× | 0.92× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $329.2M | — | ||
| Q3 25 | $318.7M | — | ||
| Q2 25 | $362.6M | — | ||
| Q1 25 | $354.0M | — | ||
| Q4 24 | $295.2M | — | ||
| Q3 24 | $388.5M | — | ||
| Q2 24 | $376.4M | — | ||
| Q1 24 | $361.8M | — |
| Q4 25 | $4.3B | $2.5B | ||
| Q3 25 | $4.4B | — | ||
| Q2 25 | $4.5B | — | ||
| Q1 25 | $4.5B | — | ||
| Q4 24 | $4.5B | $2.4B | ||
| Q3 24 | $4.6B | — | ||
| Q2 24 | $4.6B | — | ||
| Q1 24 | $4.6B | — |
| Q4 25 | $4.8B | $2.7B | ||
| Q3 25 | $4.9B | — | ||
| Q2 25 | $5.0B | — | ||
| Q1 25 | $5.0B | — | ||
| Q4 24 | $5.1B | $2.9B | ||
| Q3 24 | $5.5B | — | ||
| Q2 24 | $5.6B | — | ||
| Q1 24 | $5.9B | — |
| Q4 25 | $11.1B | $6.8B | ||
| Q3 25 | $11.2B | — | ||
| Q2 25 | $11.4B | — | ||
| Q1 25 | $11.5B | — | ||
| Q4 24 | $11.5B | $6.9B | ||
| Q3 24 | $12.0B | — | ||
| Q2 24 | $12.1B | — | ||
| Q1 24 | $12.5B | — |
| Q4 25 | 0.89× | 0.92× | ||
| Q3 25 | 0.90× | — | ||
| Q2 25 | 0.90× | — | ||
| Q1 25 | 0.90× | — | ||
| Q4 24 | 0.88× | 0.82× | ||
| Q3 24 | 0.84× | — | ||
| Q2 24 | 0.83× | — | ||
| Q1 24 | 0.79× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $159.9M | $357.2M |
| Free Cash FlowOCF − Capex | $89.2M | $272.4M |
| FCF MarginFCF / Revenue | 14.5% | 32.6% |
| Capex IntensityCapex / Revenue | 11.5% | 10.2% |
| Cash ConversionOCF / Net Profit | 51.58× | — |
| TTM Free Cash FlowTrailing 4 quarters | $365.3M | $1.3B |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $159.9M | $357.2M | ||
| Q3 25 | $181.1M | — | ||
| Q2 25 | $116.3M | — | ||
| Q1 25 | $171.2M | — | ||
| Q4 24 | $141.3M | $470.2M | ||
| Q3 24 | $202.9M | — | ||
| Q2 24 | $126.2M | — | ||
| Q1 24 | $176.2M | — |
| Q4 25 | $89.2M | $272.4M | ||
| Q3 25 | $115.5M | — | ||
| Q2 25 | $50.3M | — | ||
| Q1 25 | $110.3M | — | ||
| Q4 24 | $59.1M | $383.5M | ||
| Q3 24 | $126.3M | — | ||
| Q2 24 | $60.3M | — | ||
| Q1 24 | $111.8M | — |
| Q4 25 | 14.5% | 32.6% | ||
| Q3 25 | 18.5% | — | ||
| Q2 25 | 8.1% | — | ||
| Q1 25 | 18.6% | — | ||
| Q4 24 | 8.9% | 44.8% | ||
| Q3 24 | 20.3% | — | ||
| Q2 24 | 9.3% | — | ||
| Q1 24 | 18.0% | — |
| Q4 25 | 11.5% | 10.2% | ||
| Q3 25 | 10.5% | — | ||
| Q2 25 | 10.6% | — | ||
| Q1 25 | 10.3% | — | ||
| Q4 24 | 12.4% | 10.1% | ||
| Q3 24 | 12.3% | — | ||
| Q2 24 | 10.1% | — | ||
| Q1 24 | 10.4% | — |
| Q4 25 | 51.58× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 8.47× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CLVT
| Academia Government Group | $312.3M | 51% |
| Re Occurring Revenues | $114.1M | 18% |
| Life Sciences And Healthcare Group | $98.3M | 16% |
| Transactional Revenues | $97.1M | 16% |
NOMD
Segment breakdown not available.
